このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Optiscan Imaging 過去の業績

過去基準チェック /06

Optiscan Imagingの収益は年間平均-22.7%の割合で減少していますが、 Medical Equipment業界の収益は年間増加しています。収益は年間5.6% 8%割合で増加しています。

主要情報

-22.7%

収益成長率

-12.0%

EPS成長率

Medical Equipment 業界の成長	5.8%
収益成長率	8.0%
株主資本利益率	-33.2%
ネット・マージン	-232.4%
前回の決算情報	31 Dec 2023

Recent updates

Can You Imagine How Jubilant Optiscan Imaging's (ASX:OIL) Shareholders Feel About Its 253% Share Price Gain?

Dec 02

収支内訳

Optiscan Imaging の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

ASX:OIL 収益、費用、利益 ( )AUD Millions
日付	収益	収益	G+A経費	研究開発費
31 Dec 23	2	-5	1	3
30 Sep 23	2	-5	0	3
30 Jun 23	3	-4	0	2
31 Mar 23	2	-5	1	2
31 Dec 22	2	-5	1	2
30 Sep 22	2	-4	1	2
30 Jun 22	2	-4	0	2
31 Mar 22	2	-4	1	2
31 Dec 21	3	-3	2	2
30 Sep 21	2	-3	2	2
30 Jun 21	2	-2	1	2
31 Mar 21	2	-2	1	2
31 Dec 20	2	-1	1	1
30 Sep 20	2	-2	1	1
30 Jun 20	2	-2	1	1
31 Mar 20	2	-2	1	1
31 Dec 19	1	-2	2	1
30 Sep 19	1	-2	2	1
30 Jun 19	1	-2	2	1
31 Mar 19	2	-2	1	1
31 Dec 18	2	-2	1	2
30 Sep 18	3	-2	1	2
30 Jun 18	3	-2	2	2
31 Mar 18	3	-2	2	2
31 Dec 17	2	-2	2	2
30 Sep 17	2	-2	2	2
30 Jun 17	1	-3	2	2
31 Mar 17	1	-3	2	2
31 Dec 16	1	-3	2	1
30 Sep 16	0	-2	2	1
30 Jun 16	0	-1	1	1
31 Mar 16	0	-1	1	1
31 Dec 15	0	-1	1	1
30 Sep 15	0	-1	1	1
30 Jun 15	0	-1	1	1
31 Mar 15	0	-1	1	1
31 Dec 14	0	-1	1	1
30 Sep 14	0	-1	1	1
30 Jun 14	0	-1	1	1
31 Mar 14	0	-2	1	1
31 Dec 13	0	-2	1	1
30 Sep 13	1	-1	1	1
30 Jun 13	1	-1	2	2

質の高い収益: OILは現在利益が出ていません。

利益率の向上: OILは現在利益が出ていません。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: OILは利益が出ておらず、過去 5 年間で損失は年間22.7%の割合で増加しています。

成長の加速: OILの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: OILは利益が出ていないため、過去 1 年間の収益成長をMedical Equipment業界 ( 10.1% ) と比較することは困難です。

株主資本利益率

高いROE: OILは現在利益が出ていないため、自己資本利益率 ( -33.19% ) はマイナスです。

Optiscan Imaging 過去の業績

過去 基準チェック /06

主要情報

最近の業績更新

Full year 2023 earnings released: AU$0.007 loss per share (vs AU$0.007 loss in FY 2022)

First half 2023 earnings released: AU$0.004 loss per share (vs AU$0.003 loss in 1H 2022)

Full year 2022 earnings released: AU$0.007 loss per share (vs AU$0.004 loss in FY 2021)

Full year 2021 earnings released: AU$0.004 loss per share (vs AU$0.004 loss in FY 2020)

Full year earnings released - AU$0.0037 loss per share

Recent updates

New minor risk - Share price stability

Optiscan Imaging Limited Appoints Brendan Fafiani to the Role of Chief Operating Officer, Effective 6 November 2023

Full year 2023 earnings released: AU$0.007 loss per share (vs AU$0.007 loss in FY 2022)

Optiscan Imaging Limited, Annual General Meeting, Nov 23, 2023

New minor risk - Financial data availability

New minor risk - Shareholder dilution

First half 2023 earnings released: AU$0.004 loss per share (vs AU$0.003 loss in 1H 2022)

We're Keeping An Eye On Optiscan Imaging's (ASX:OIL) Cash Burn Rate

Less than half of directors are independent

We're Keeping An Eye On Optiscan Imaging's (ASX:OIL) Cash Burn Rate

Full year 2022 earnings released: AU$0.007 loss per share (vs AU$0.004 loss in FY 2021)

Optiscan Imaging Limited, Annual General Meeting, Nov 24, 2022

Optiscan Submits FDA 510(k) Application for InVivage Device

Insider recently bought AU$1.9m worth of stock

Optiscan Imaging Limited Appointment of Sean Gardiner as Non-Executive Director

We're Not Very Worried About Optiscan Imaging's (ASX:OIL) Cash Burn Rate

Less than half of directors are independent

Insider recently bought AU$1.2m worth of stock

Insider recently bought AU$1.4m worth of stock

Optiscan Imaging (ASX:OIL) Is In A Strong Position To Grow Its Business

Full year 2021 earnings released: AU$0.004 loss per share (vs AU$0.004 loss in FY 2020)

Non-Executive Director Graeme Mutton has left the company

We're Not Worried About Optiscan Imaging's (ASX:OIL) Cash Burn

Optiscan Imaging Limited Announces Update on seeking United States FDA approval & market entry

How Much Of Optiscan Imaging Limited (ASX:OIL) Do Insiders Own?

New 90-day high: AU$0.23

Optiscan Imaging Limited Announces Appointment of Ron Song as New Non-Executive Director

Optiscan Imaging Limited Announces Commencement of Stage Three of its Breast Cancer Study in Melbourne

OptiScan Imaging Limited Receives Orders from Carl Zeiss Meditec AG

Can You Imagine How Jubilant Optiscan Imaging's (ASX:OIL) Shareholders Feel About Its 253% Share Price Gain?

Optiscan Imaging Limited Announces US FDA Regulatory Approval Update

Optiscan Imaging Limited announced that it expects to receive AUD 9.813499 million in funding from Orchid Fund Pte. Limited and other investors

Optiscan Imaging Limited Auditor Raises 'Going Concern' Doubt

Full year earnings released - AU$0.0037 loss per share

Optiscan Image Ltd Ordinary Shares to Be Deleted from Other OTC

収支内訳

収益と収入の歴史

フリー・キャッシュフローと収益の比較

過去の収益成長分析

株主資本利益率

総資産利益率

使用総資本利益率

過去の好業績企業の発掘

過去基準チェック /06